Treatment of Cellulitis
First-Line Antibiotic Therapy
Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis and should be used in 96% of cases, as MRSA coverage is unnecessary for nonpurulent cellulitis without specific risk factors. 1
Recommended Oral Agents for Outpatient Treatment
- Cephalexin 500 mg four times daily is a preferred first-line option for typical cellulitis 1
- Dicloxacillin 250-500 mg every 6 hours provides excellent streptococcal and methicillin-sensitive S. aureus coverage 1
- Amoxicillin is appropriate for typical nonpurulent cellulitis 1
- Penicillin V 250-500 mg four times daily is an alternative option 1
- Amoxicillin-clavulanate (Augmentin) 875/125 mg twice daily should be reserved specifically for bite-associated cellulitis (human or animal) 1
Treatment Duration
Treat for exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 1 This represents a major shift from traditional 7-14 day courses and is supported by high-quality randomized controlled trial evidence 1. The 5-day duration applies whether using oral or IV antibiotics 1.
When to Add MRSA Coverage
Do NOT routinely add MRSA coverage for typical nonpurulent cellulitis. 1 MRSA is an uncommon cause of typical cellulitis even in hospitals with high MRSA prevalence 1.
Specific Indications for MRSA-Active Antibiotics
Add MRSA coverage ONLY when these risk factors are present:
- Penetrating trauma or injection drug use 1
- Purulent drainage or exudate 1
- Known MRSA colonization or evidence of MRSA infection elsewhere 1
- Systemic inflammatory response syndrome (SIRS) with fever >38°C, tachycardia >90 bpm, or tachypnea >24 rpm 1
MRSA-Active Regimens When Indicated
- Clindamycin 300-450 mg orally every 6 hours provides single-agent coverage for both streptococci and MRSA, avoiding the need for combination therapy 1 (use only if local MRSA clindamycin resistance <10%) 1
- Trimethoprim-sulfamethoxazole (Bactrim) PLUS a beta-lactam (e.g., cephalexin) for combination coverage 1
- Doxycycline 100 mg orally twice daily PLUS a beta-lactam 1
Critical pitfall: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis, as their activity against beta-hemolytic streptococci is unreliable 1.
Inpatient IV Antibiotic Selection
Indications for Hospitalization
Hospitalize if ANY of the following are present:
- Systemic inflammatory response syndrome (SIRS), fever, hypotension, or altered mental status 1
- Severe immunocompromise or neutropenia 1
- Concern for necrotizing fasciitis or deeper infection 1
Standard IV Therapy for Uncomplicated Cellulitis Requiring Hospitalization
- Cefazolin 1-2 g IV every 8 hours is the preferred IV beta-lactam for hospitalized patients without MRSA risk factors 1
- Oxacillin 2 g IV every 6 hours or nafcillin 2 g IV every 6 hours are alternatives 1
IV Therapy for Complicated Cellulitis with MRSA Risk Factors
- Vancomycin 15-20 mg/kg IV every 8-12 hours is first-line with A-I level evidence 1
- Linezolid 600 mg IV twice daily is equally effective (A-I evidence) 1
- Daptomycin 4 mg/kg IV once daily is an alternative (A-I evidence) 1
- Clindamycin 600 mg IV every 8 hours if local MRSA resistance <10% (A-III evidence) 1
Severe Cellulitis with Systemic Toxicity
For patients with signs of systemic toxicity, rapid progression, or suspected necrotizing fasciitis, mandatory broad-spectrum combination therapy is required. 1
Recommended IV Combination Regimens
- Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
- Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
- Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1
- Vancomycin PLUS ceftriaxone 2 g IV daily and metronidazole 500 mg IV every 8 hours 1
For documented group A streptococcal necrotizing fasciitis specifically: Use penicillin plus clindamycin 1
Treatment duration for severe infections is 7-14 days, guided by clinical response 1.
Essential Adjunctive Measures
These are often neglected but critical for treatment success:
- Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema 1
- Examine interdigital toe spaces for tinea pedis (fissuring, scaling, maceration) and treat to eradicate colonization and reduce recurrence 1
- Treat predisposing conditions: venous insufficiency, lymphedema, chronic edema, eczema, and obesity 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1
Special Populations and Situations
Penicillin/Cephalosporin Allergy
- Clindamycin 300-450 mg orally every 6 hours is the optimal choice, providing single-agent coverage for both streptococci and MRSA 1
- Levofloxacin 500 mg daily can be used but should be reserved for patients with beta-lactam allergies 1
Diabetic Foot Cellulitis
- Amoxicillin-clavulanate, ampicillin-sulbactam, or second/third-generation cephalosporins (cefuroxime, cefotaxime, ceftriaxone) for moderate infections 1
Pediatric Dosing
- Vancomycin 15 mg/kg IV every 6 hours for hospitalized children with complicated cellulitis 1
- Clindamycin 10-13 mg/kg/dose IV every 6-8 hours if stable, no bacteremia, and local resistance <10% 1
- Linezolid: 600 mg IV twice daily for children >12 years, or 10 mg/kg/dose IV every 8 hours for children <12 years 1
Transition to Oral Therapy
Patients can transition to oral antibiotics once clinical improvement is demonstrated, typically after a minimum of 4 days of IV treatment. 1 Use cephalexin, dicloxacillin, or clindamycin for continued coverage 1.
Prevention of Recurrent Cellulitis
Annual recurrence rates are 8-20% in patients with previous cellulitis 1.
Prophylactic Antibiotics
For patients with 3-4 episodes per year despite treating predisposing factors:
- Penicillin V 250 mg orally twice daily 1
- Erythromycin 250 mg twice daily 1
- Intramuscular benzathine penicillin 2
Critical Warning Signs Requiring Immediate Reassessment
If cellulitis spreads despite appropriate antibiotics within 24-48 hours, immediately evaluate for: 1
- Necrotizing fasciitis: severe pain out of proportion to examination, skin anesthesia, rapid progression, gas in tissue, bullous changes 1
- MRSA involvement if not initially covered 1
- Misdiagnosis: consider pseudocellulitis (venous stasis dermatitis, contact dermatitis, DVT) 3, 4
Obtain emergent surgical consultation if necrotizing infection is suspected, as these progress rapidly and require debridement. 1